NEW YORK (GenomeWeb News) – PBL Assay Science announced today a licensing agreement to provide human cell-expressed cytokines and growth factors from HumanZyme to researchers.

The deal, which takes effect this month, covers about 50 HCE cytokines and growth factors, including members of the human TGF beta, fibroblast growth factor, hematopoietin and interleukin, and tyrosine kinase receptor signaling families, as well as TNF-alpha.

Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.